Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Execs On The Move: Shakeup At Milestone Medical, And More

Executive Summary

Milestone Medical has seen a near-total reshuffle of its board, appointing a new CEO, and NuVasive's Daniel Wolterman is now its chairman.

You may also be interested in...



Terns Says Phase IIa Data Show Superior NASH Safety Profile In FXR Class

TERN-101 showed a superior safety and tolerability profile for lipid levels and pruritis compared to other FXR agonists in a mid-stage study. Terns is now looking to a NASH combo study with its THR beta agonist.

Coordinating EU Market Surveillance For The First Time: Pilot Being Launched

‘JAMS’ has been strengthening the European market surveillance network and helping lower-resourced member states develop skills and capacity. Coordinated pilot project work is next.

Colgate Prioritizes Growing Brands Over Adding More; Increasing Costs Drive Prices Higher

Colgate is “not in a hurry” to make deals with valuations high for businesses it would target, says CEO Noel Wallace. Increasing commodity costs and rising inflation have the company prioritizing growth on existing businesses.

Topics

UsernamePublicRestriction

Register

MT143987

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel